<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:department>The Wolfson Inst for Biomedical Research</gtr:department><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/2E792D8C-51F8-454F-9A00-444F49E05999"><gtr:id>2E792D8C-51F8-454F-9A00-444F49E05999</gtr:id><gtr:firstName>James</gtr:firstName><gtr:otherNames>John</gtr:otherNames><gtr:surname>Cox</gtr:surname><gtr:orcidId>0000-0002-9129-8011</gtr:orcidId><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G1100340"><gtr:id>68135BBC-E40E-4850-B81B-A49D06362AA6</gtr:id><gtr:title>New insights into pain mechanisms</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Fellowship</gtr:grantCategory><gtr:grantReference>G1100340</gtr:grantReference><gtr:abstractText>To feel pain is a good thing because it persuades you to protect yourself from danger and it helps you to heal after hurting a part of your body. But, sometimes, pain is not useful and it can torment you long after an old injury has healed. To add to the misery, pain treatments are often only partially effective with side effects being common. My work aims to help us to better understand and treat pain. Everyone is born with a ?library? of ?instruction books? called genes, which describe how to carry out jobs such as building a heart. Unfortunately, a book can sometimes contain an error called a mutation; and if the book describes a very important job, then this can result in a disease. I work with patients who either can?t feel pain or who have episodes of excruciating pain and I try to find mutations by using amazing sequencing technology, which can rapidly read all ~23000 human genes. Once a mutation has been found I can learn how the error causes disease, e.g. pain insensitivity, by looking at how the comparable gene works in mice. This can, ultimately, lead to the development of better pain-killing drugs.</gtr:abstractText><gtr:technicalSummary>At any one time 6% of the population is in severe pain. Despite this huge clinical burden, our understanding of the cellular mechanisms involved in pain processing is limited and the treatments available are often only partially effective. I study rare families in which pain insensitivity or paroxysmal pain are caused by a mutation in a single gene in order to gain powerful insights into pain mechanisms and to give a route to new therapies. This is exemplified by my previous work showing that Channelopathy-associated Insensitivity to Pain (CIP) is caused by loss of function of Nav1.7, a nociceptor-expressed voltage-gated sodium channel; and by Familial Episodic Pain Syndrome which was shown to be caused by an activating mutation in TRPA1, the chemosensitive transient receptor potential channel. This proposal aims to further characterize the function of Nav1.7 through the analysis of two C-terminal CIP mutations and find other crucial genes involved in human pain sensing which I will then extensively study by generating and analysing mouse mutants. Through collaborations with European-based pain clinicians I have access to a rich cohort of patients with Mendelian pain disorders in which known disease genes have been excluded. This cohort includes (1) a three generation family with 6 affected individuals with pain insensitivity that segregates autosomal dominantly; (2) three consanguineous families with pain insensitivity due to congenital or progressive neuropathies; (3) four singletons with complete absence of pain sensation but with peripheral nerves intact; (4) a collection of patients with paroxysmal pain disorders (including paroxysmal pain and congenital erythermalgia); (5) a mother and daughter with extreme cold allodynia; and (6) three individuals who cannot sense cold pain. The strategy which will be adopted to find each disease gene will involve the use of whole exome sequencing, which is already being performed in a collaborating laboratory for a subset of this cohort. Once the disease genes are proven I will prioritise two of the most interesting for transgenic mouse creation and characterize the pain phenotype using appropriate behavioural, anatomical and electrophysiological assays. The mouse mutant analysis will capitalize on expertise in the Wood lab who routinely use the Cre-Lox P approach to conditionally knock out genes. By identifying and functionally characterizing novel pain genes this proposal has the real potential to lead to a better understanding of pain production and could lead to the development of better analgesics which will benefit us all.</gtr:technicalSummary><gtr:fund><gtr:end>2016-09-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2011-10-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>1183598</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Institute of Neurology</gtr:department><gtr:description>Molecular Nociception Group</gtr:description><gtr:id>14DFDBEC-73E3-47A4-9CD6-8BFBACDE1161</gtr:id><gtr:impact>26634308; 26035178; 25846613; 25316021; 25253744; 24866741; 24165728 ; 23575686; 23292638; 22911851; 22724068; 23487782</gtr:impact><gtr:outcomeId>58c7c3423117e9.82341780-1</gtr:outcomeId><gtr:partnerContribution>Expertise in the field of pain and mouse genetics. Molecular Nociception Group staff helped to train my team.</gtr:partnerContribution><gtr:piContribution>Expertise in human genetics.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Cambridge</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Cambridge Institute for Medical Research (CIMR)</gtr:department><gtr:description>CIMR</gtr:description><gtr:id>8151127F-CAC0-461C-9B86-5B9EAE18ACBF</gtr:id><gtr:impact>26035178; 25995458; 25316021; 22911851;</gtr:impact><gtr:outcomeId>58c7c474762699.65464260-1</gtr:outcomeId><gtr:partnerContribution>Clinical expertise in human pain genetics.</gtr:partnerContribution><gtr:piContribution>Expertise in human and mouse genetics.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Nuffield Department of Clinical Neurosciences</gtr:department><gtr:description>Oxford</gtr:description><gtr:id>8D3EA0A0-9A91-4DC0-A0FD-691D21AFD9A0</gtr:id><gtr:impact>25253744; 24866741; 23292638;</gtr:impact><gtr:outcomeId>58c7c548c20f02.28765667-1</gtr:outcomeId><gtr:partnerContribution>Expertise in clinical pain genetics.</gtr:partnerContribution><gtr:piContribution>Expertise in human genetics.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Understanding Pain: Human Mendelian Pain Disorders Webinar</gtr:description><gtr:form>A broadcast e.g. TV/radio/film/podcast (other than news/press)</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>E4511757-FF6C-40BA-8063-1D2EC342DD75</gtr:id><gtr:impact>I presented a live webinar about the work carried out in my MRC Fellowship about human Mendelian pain disorders. This webinar is now available on demand on the Abcam website. Several questions were asked at the end of the webinar and the organiser's reported that 80 people subscribed.</gtr:impact><gtr:outcomeId>56e12eedc92f56.27774359</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:url>http://www.abcam.com/webinars/understanding-pain-human-mendelian-pain-disorders-part-1-of-2</gtr:url><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Science Week at local primary school (Downham Feoffees)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>33BA845F-C771-4F2E-A0A4-4720A8C7B0AF</gtr:id><gtr:impact>My post-doc and I attended the local primary school to take part in Science Week. We taught a lesson on DNA to a Year 4 class and the children took part in an experiment to isolate DNA. The children were excited to do an experiment and asked lots of questions. The lesson was voted as their favourite at the end of the week.

In 2016 we again participated in Science Week where we gave a lesson about 'senses'.</gtr:impact><gtr:outcomeId>56e12cb383c192.14128317</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2015,2016</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>198842</gtr:amountPounds><gtr:country>Japan</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Research collaboration grant</gtr:description><gtr:end>2016-12-02</gtr:end><gtr:fundingOrg>Shionogi &amp; Co., Ltd.</gtr:fundingOrg><gtr:id>B13D43BA-1D0B-4E36-AB41-0EC89A5A8470</gtr:id><gtr:outcomeId>545bb22ed04d82.74506452</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2014-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>3631275</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome collaborative award</gtr:description><gtr:end>2021-04-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>F1D3828F-50EC-4D18-A4D5-819E67CAAFDC</gtr:id><gtr:outcomeId>56e09fa5572251.19960574</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2016-05-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Generated a new knockout mouse line derived from EUCOMM ES cells</gtr:description><gtr:id>CF5BCA03-1899-455F-87B6-B5983C45ECDF</gtr:id><gtr:impact>Enabled us to study the effects of knocking out a candidate gene for pain insensitivity.</gtr:impact><gtr:outcomeId>58c7b45f811f29.15152522</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Knockout mouse model</gtr:title><gtr:type>Model of mechanisms or symptoms - mammalian in vivo</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Lymphoblastoid and fibroblast cell lines derived from pain insensitive patients</gtr:description><gtr:id>C265CC70-1A1B-457C-80D5-509DC3270716</gtr:id><gtr:impact>Enables research to be carried out in human cell lines to understand pathogenicity of mutations prior to decision about whether to make a mouse model.</gtr:impact><gtr:outcomeId>58c7b35280f4b5.27731602</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Patient derived cell lines</gtr:title><gtr:type>Cell line</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>DF570A43-3CFE-482F-AE1F-9983E7D06C39</gtr:id><gtr:title>No pain, more gain.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/47d52ce5cf737af5897ceb23de3e4447"><gtr:id>47d52ce5cf737af5897ceb23de3e4447</gtr:id><gtr:otherNames>Cox JJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>pm_15550_20_24165728</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F31D9BCF-171F-4814-A45F-F666C904BB09</gtr:id><gtr:title>Novel mutations mapping to the fourth sodium channel domain of Nav1.7 result in variable clinical manifestations of primary erythromelalgia.</gtr:title><gtr:parentPublicationTitle>Neuromolecular medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7276d1e256346a632b0a5edf660a0b74"><gtr:id>7276d1e256346a632b0a5edf660a0b74</gtr:id><gtr:otherNames>Cregg R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1535-1084</gtr:issn><gtr:outcomeId>pm_15550_20_23292638</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>98D5E146-48ED-4741-9765-B8BD5A870C75</gtr:id><gtr:title>Splice variants of Na(V)1.7 sodium channels have distinct ? subunit-dependent biophysical properties.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6ccc2d2b825dc095a461ecde19f7dece"><gtr:id>6ccc2d2b825dc095a461ecde19f7dece</gtr:id><gtr:otherNames>Farmer C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_15550_20_22911851</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A6F167EF-0B0E-4F91-B798-1B004E6E431A</gtr:id><gtr:title>TRPC3 and TRPC6 are essential for normal mechanotransduction in subsets of sensory neurons and cochlear hair cells.</gtr:title><gtr:parentPublicationTitle>Open biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7d71f0e8d4c37a25f5cde660579fb11a"><gtr:id>7d71f0e8d4c37a25f5cde660579fb11a</gtr:id><gtr:otherNames>Quick K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>2046-2441</gtr:issn><gtr:outcomeId>pm_15550_20_22724068</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C7655BB3-ED82-4191-9A70-1BD8E3D3B6CE</gtr:id><gtr:title>Sodium channels and pain.</gtr:title><gtr:parentPublicationTitle>Handbook of experimental pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2b376d10bfb8c4c22a03eb295b788e59"><gtr:id>2b376d10bfb8c4c22a03eb295b788e59</gtr:id><gtr:otherNames>Habib AM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0171-2004</gtr:issn><gtr:outcomeId>56e07b30a39e06.80036732</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0AB0F651-EAFF-44C4-9A8B-AA42CE2663D2</gtr:id><gtr:title>A role for Piezo2 in EPAC1-dependent mechanical allodynia.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/de2ecc92d2fdbd6589be0f159e2a94d4"><gtr:id>de2ecc92d2fdbd6589be0f159e2a94d4</gtr:id><gtr:otherNames>Eijkelkamp N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>pm_15550_20_23575686</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2C132D5F-8E70-4F74-B454-D30CED12E8CE</gtr:id><gtr:title>Mexiletine as a treatment for primary erythromelalgia: normalization of biophysical properties of mutant L858F NaV 1.7 sodium channels.</gtr:title><gtr:parentPublicationTitle>British journal of pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7276d1e256346a632b0a5edf660a0b74"><gtr:id>7276d1e256346a632b0a5edf660a0b74</gtr:id><gtr:otherNames>Cregg R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0007-1188</gtr:issn><gtr:outcomeId>545bafe522df49.13215321</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2F95591A-A1EE-4FFF-9871-2C1945E91946</gtr:id><gtr:title>Gain-of-function mutations in the mechanically activated ion channel PIEZO2 cause a subtype of Distal Arthrogryposis.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9db1220f520e731fa5d9b7e6f9901af0"><gtr:id>9db1220f520e731fa5d9b7e6f9901af0</gtr:id><gtr:otherNames>Coste B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>pm_15550_20_23487782</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5C26E754-5FE9-48FA-A738-541D6B6A4F87</gtr:id><gtr:title>Sodium channel genes in pain-related disorders: phenotype-genotype associations and recommendations for clinical use.</gtr:title><gtr:parentPublicationTitle>The Lancet. Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ce3a3e72d2229b0fa33500c7ccc94999"><gtr:id>ce3a3e72d2229b0fa33500c7ccc94999</gtr:id><gtr:otherNames>Waxman SG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1474-4422</gtr:issn><gtr:outcomeId>545bafe4c0e906.14700365</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>61D300E9-68B7-4E9C-B72F-3CEF3D0E8010</gtr:id><gtr:title>The Genetics of Pain: Implications for Therapeutics.</gtr:title><gtr:parentPublicationTitle>Annual review of pharmacology and toxicology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e9324f62c3d0034c69aab0c07c81fe25"><gtr:id>e9324f62c3d0034c69aab0c07c81fe25</gtr:id><gtr:otherNames>Sexton JE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0362-1642</gtr:issn><gtr:outcomeId>5a0069af9955e7.58370325</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>13893EC1-53D4-473C-8259-1561A3E68D68</gtr:id><gtr:title>Regulation of Nav1.7: A Conserved SCN9A Natural Antisense Transcript Expressed in Dorsal Root Ganglia.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/baa2ea7f1dbc24f0907f9f104ac47691"><gtr:id>baa2ea7f1dbc24f0907f9f104ac47691</gtr:id><gtr:otherNames>Koenig J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>5675e5aed10ea</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ED0F29AC-1B02-4E8D-A427-7BC5429AFE20</gtr:id><gtr:title>A novel human pain insensitivity disorder caused by a point mutation in ZFHX2.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2b376d10bfb8c4c22a03eb295b788e59"><gtr:id>2b376d10bfb8c4c22a03eb295b788e59</gtr:id><gtr:otherNames>Habib AM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>5a995f879e2709.47895097</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>02C6BDB7-C74D-41C5-8223-93D4B15B7323</gtr:id><gtr:title>Rare NaV1.7 variants associated with painful diabetic peripheral neuropathy.</gtr:title><gtr:parentPublicationTitle>Pain</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1587124734528fdf05f3e9404a08927f"><gtr:id>1587124734528fdf05f3e9404a08927f</gtr:id><gtr:otherNames>Blesneac I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0304-3959</gtr:issn><gtr:outcomeId>5aa5aeb1268495.78964308</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0D1F91B2-98D0-4C01-A997-DBB9C6D93D76</gtr:id><gtr:title>Endogenous opioids contribute to insensitivity to pain in humans and mice lacking sodium channel Nav1.7.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ee9c5e67b6d40f0778e53130a97ab23d"><gtr:id>ee9c5e67b6d40f0778e53130a97ab23d</gtr:id><gtr:otherNames>Minett MS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>56e07a329d9788.57546410</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4E690B31-F53E-42CB-9C4A-C9870389C876</gtr:id><gtr:title>Null mutation in SCN9A in which noxious stimuli can be detected in the absence of pain.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/50e4878389642910b2d3b2db93ee77f8"><gtr:id>50e4878389642910b2d3b2db93ee77f8</gtr:id><gtr:otherNames>Ramirez JD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>545bafe4ece1d5.99520134</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>03EBE9D0-4226-4C96-A76A-EE92022C7FCA</gtr:id><gtr:title>Mapping protein interactions of sodium channel Na1.7 using epitope-tagged gene-targeted mice.</gtr:title><gtr:parentPublicationTitle>The EMBO journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/145f23a0441e2bc18ad4f0e9eff5bfdb"><gtr:id>145f23a0441e2bc18ad4f0e9eff5bfdb</gtr:id><gtr:otherNames>Kanellopoulos AH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0261-4189</gtr:issn><gtr:outcomeId>5a6790ccedeec1.28977641</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>49FF6089-496E-403C-8014-7210869C128D</gtr:id><gtr:title>Novel SCN9A mutations underlying extreme pain phenotypes: unexpected electrophysiological and clinical phenotype correlations.</gtr:title><gtr:parentPublicationTitle>The Journal of neuroscience : the official journal of the Society for Neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/01ff1d73e3cd6ea16954f9aef519f837"><gtr:id>01ff1d73e3cd6ea16954f9aef519f837</gtr:id><gtr:otherNames>Emery EC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0270-6474</gtr:issn><gtr:outcomeId>56e07a32d0fd27.53335366</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3C6DC3A3-8235-4325-B3E1-CCCAA94F90D4</gtr:id><gtr:title>Pain in Fabry disease: Plasma lipids sensitise nociceptors.</gtr:title><gtr:parentPublicationTitle>Neuroscience letters</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2b376d10bfb8c4c22a03eb295b788e59"><gtr:id>2b376d10bfb8c4c22a03eb295b788e59</gtr:id><gtr:otherNames>Habib AM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0304-3940</gtr:issn><gtr:outcomeId>56e07b30d153c7.06868648</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G1100340</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>041997EB-CFD8-493D-B0F8-DFA35451D0BE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Neurological</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>